BRPI0919977A2 - Derivados de 7-hidróxi-benzoimidazol-4-il-metanona e inibidores de pbk contendo os mesmos - Google Patents
Derivados de 7-hidróxi-benzoimidazol-4-il-metanona e inibidores de pbk contendo os mesmosInfo
- Publication number
- BRPI0919977A2 BRPI0919977A2 BRPI0919977-2A BRPI0919977A BRPI0919977A2 BR PI0919977 A2 BRPI0919977 A2 BR PI0919977A2 BR PI0919977 A BRPI0919977 A BR PI0919977A BR PI0919977 A2 BRPI0919977 A2 BR PI0919977A2
- Authority
- BR
- Brazil
- Prior art keywords
- benzoimidazol
- hydroxy
- containing same
- inhibitors containing
- methanone derivatives
- Prior art date
Links
- GGRAFBSODPLTOT-UHFFFAOYSA-N 7-hydroxy-1h-benzimidazole-4-carbaldehyde Chemical class OC1=CC=C(C=O)C2=C1N=CN2 GGRAFBSODPLTOT-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10980108P | 2008-10-30 | 2008-10-30 | |
| PCT/US2009/052228 WO2010051085A1 (en) | 2008-10-30 | 2009-07-30 | 7-hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0919977A2 true BRPI0919977A2 (pt) | 2015-08-25 |
Family
ID=42129188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0919977-2A BRPI0919977A2 (pt) | 2008-10-30 | 2009-07-30 | Derivados de 7-hidróxi-benzoimidazol-4-il-metanona e inibidores de pbk contendo os mesmos |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20110263566A1 (enExample) |
| EP (1) | EP2364087A4 (enExample) |
| JP (1) | JP2012507525A (enExample) |
| KR (1) | KR20110079847A (enExample) |
| CN (1) | CN102271514A (enExample) |
| AU (1) | AU2009310310A1 (enExample) |
| BR (1) | BRPI0919977A2 (enExample) |
| CA (1) | CA2741988A1 (enExample) |
| CO (1) | CO6361855A2 (enExample) |
| IL (1) | IL212544A0 (enExample) |
| MX (1) | MX2011004414A (enExample) |
| RU (1) | RU2011121665A (enExample) |
| WO (1) | WO2010051085A1 (enExample) |
| ZA (1) | ZA201103964B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0716498A2 (pt) | 2006-08-10 | 2015-01-27 | Oncotherapy Science Inc | Genes e polipeptídeos relacionados a cânceres de mama |
| JP2011529903A (ja) * | 2008-07-30 | 2011-12-15 | オンコセラピー・サイエンス株式会社 | ベンゾイミダゾール誘導体およびこれを含むグリコーゲンシンターゼキナーゼ３β阻害剤 |
| EP2358365A4 (en) * | 2008-11-20 | 2012-05-30 | Oncotherapy Science Inc | GLYCOGEN SYNTHASE KINASE 3 BETA HEMMER WITH 7-HYDROXY BENZOIMIDAZOLE-4-YL METHANONE DERIVATIVES |
| CN101619058A (zh) * | 2009-01-08 | 2010-01-06 | 上海交通大学 | 一种苯并咪唑-4-酰胺型衍生物 |
| CN104854087B (zh) * | 2012-12-18 | 2017-03-22 | 埃科特莱茵药品有限公司 | 作为p2x7受体拮抗剂的吲哚羧酰胺衍生物 |
| CN105017221B (zh) * | 2014-04-30 | 2019-05-28 | 中国医学科学院药物研究所 | 苯并咪唑衍生物及其制法和药物组合物与用途 |
| JP6009135B1 (ja) * | 2015-07-30 | 2016-10-19 | 第一三共株式会社 | 成人ｔ細胞白血病リンパ腫の治療及び／又は予防剤 |
| CA2993605C (en) * | 2015-07-30 | 2020-01-07 | Daiichi Sankyo Company, Limited | 1,3-benzodioxole derivatives for the treatment or prevention of adult t cell leukemia/lymphoma |
| WO2019124608A1 (ko) * | 2017-12-22 | 2019-06-27 | 경상대학교병원 | 4'-(p-톨루엔설포닐아미도)-4-하이드록시칼콘을 유효성분으로 함유하는 류마티스 관절염 예방 또는 치료용 약학 조성물 |
| CN109320461B (zh) * | 2018-12-12 | 2020-02-07 | 迪嘉药业集团有限公司 | 一种替米沙坦中间体的制备方法 |
| US11198699B2 (en) | 2019-04-02 | 2021-12-14 | Aligos Therapeutics, Inc. | Compounds targeting PRMT5 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6288100B1 (en) * | 1995-06-06 | 2001-09-11 | American Home Products Corporation | Benzimidazole derivatives |
| US20040002524A1 (en) * | 2002-06-24 | 2004-01-01 | Richard Chesworth | Benzimidazole compounds and their use as estrogen agonists/antagonists |
| KR100791252B1 (ko) * | 2003-01-23 | 2008-01-03 | 크리스탈지노믹스(주) | 글리코겐 합성효소 키나아제 3β 활성 억제제, 이의제조방법 및 이를 유효성분으로 함유하는 약학 조성물 |
-
2009
- 2009-07-30 AU AU2009310310A patent/AU2009310310A1/en not_active Withdrawn
- 2009-07-30 JP JP2011534550A patent/JP2012507525A/ja not_active Withdrawn
- 2009-07-30 MX MX2011004414A patent/MX2011004414A/es unknown
- 2009-07-30 BR BRPI0919977-2A patent/BRPI0919977A2/pt not_active IP Right Cessation
- 2009-07-30 EP EP09823973A patent/EP2364087A4/en not_active Withdrawn
- 2009-07-30 CA CA2741988A patent/CA2741988A1/en not_active Abandoned
- 2009-07-30 CN CN2009801533867A patent/CN102271514A/zh not_active Withdrawn
- 2009-07-30 US US13/126,741 patent/US20110263566A1/en not_active Abandoned
- 2009-07-30 KR KR1020117011835A patent/KR20110079847A/ko not_active Withdrawn
- 2009-07-30 WO PCT/US2009/052228 patent/WO2010051085A1/en not_active Ceased
- 2009-07-30 RU RU2011121665/13A patent/RU2011121665A/ru not_active Application Discontinuation
-
2011
- 2011-04-28 IL IL212544A patent/IL212544A0/en unknown
- 2011-05-17 CO CO11060496A patent/CO6361855A2/es not_active Application Discontinuation
- 2011-05-30 ZA ZA2011/03964A patent/ZA201103964B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO6361855A2 (es) | 2012-01-20 |
| AU2009310310A2 (en) | 2011-10-06 |
| IL212544A0 (en) | 2011-06-30 |
| EP2364087A4 (en) | 2012-05-30 |
| US20110263566A1 (en) | 2011-10-27 |
| CN102271514A (zh) | 2011-12-07 |
| ZA201103964B (en) | 2012-02-29 |
| WO2010051085A1 (en) | 2010-05-06 |
| RU2011121665A (ru) | 2012-12-10 |
| MX2011004414A (es) | 2011-06-21 |
| JP2012507525A (ja) | 2012-03-29 |
| AU2009310310A1 (en) | 2010-05-06 |
| EP2364087A1 (en) | 2011-09-14 |
| CA2741988A1 (en) | 2010-05-06 |
| KR20110079847A (ko) | 2011-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2020024I2 (el) | Αναστολεiς βητα-λακταμασων | |
| BRPI0919977A2 (pt) | Derivados de 7-hidróxi-benzoimidazol-4-il-metanona e inibidores de pbk contendo os mesmos | |
| CY2017016I1 (el) | Αναστολεις πρωτεασωματος | |
| BRPI0906980A2 (pt) | Composição de derivados e maleatados | |
| EP2192838A4 (en) | HETEROCYCLIC NEKROPTOSIS HEMMER | |
| HRP20190016T1 (hr) | Heterociklički spojevi i njihova upotreba | |
| BRPI0918846A2 (pt) | inibidores de cinase heterocíclica | |
| BRPI0908906A2 (pt) | compostos heterocíclicos e usos dos mesmos | |
| ATE549340T1 (de) | Spiroindolinon-derivate als mdm2-p53 inhibitoren | |
| DK2164844T3 (da) | Pyrimidinyl-pyridazinonderivater | |
| CR10478A (es) | Amino-piperidine derivatives as cetp inhibitors | |
| DK2209786T3 (da) | Pyrimidinsubstituerede purinderivater | |
| BRPI0915064A2 (pt) | derivados de qunoxalinadiona | |
| BRPI0813836A2 (pt) | Derivados pirazólicos | |
| HRP20180718T1 (hr) | Oligopeptidni spojevi i njihova upotreba | |
| BRPI0918564A2 (pt) | inibidores | |
| CR20130360A (es) | Compuesto heterocíclico y su uso | |
| BRPI0913832A2 (pt) | derivados de pirrolopiridinilpirimidin-2-ilamina | |
| ATE506358T1 (de) | 2-benzylpyridazinonderivate als met-kinasehemmer | |
| ATE518837T1 (de) | Indazolamidderivate | |
| CR10879A (es) | Cyclized derivatives as eg-5 inhibitors | |
| DK2275414T3 (da) | Cyclopentylacrylamidderivat | |
| DK2152370T3 (da) | Aryletherpyridazinonderivater | |
| DK2142533T3 (da) | Imidazolidinonderivater | |
| DK2318378T3 (da) | Quinazolin-derivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |